found that treatment with IL-18 secreting TRUCKs directed against carcinoembryonic antigen (CEA), enhanced CAR-T cell function and survival of mice with advanced pancreatic and lung cancers, and induced an acute Th1 inflammatory response. This evidence concerns the gene CEACAM5 and lung cancer.